Circadian Health Named Winner in HLTH Foundation's 2nd Annual Techquity for Health Case Study Awards

Recognized for Advancing Equitable, Technology-Enabled Diabetes Care for Medicaid Populations

, /PRNewswire/ -- Circadian Health, a pioneering leader in virtual-first specialty care, has been named a Winner in the 2025 HLTH Foundation's 2nd Annual Techquity for Health Case Study Awards for its work in addressing systemic inequities in diabetes care among urban Medicaid populations. This award highlights Circadian's efforts to bridge the technology divide in diabetes management by expanding access to advanced tools and personalized specialty care for African American and Asian patients in Brooklyn and Queens, New York.

"HLTH Foundation's Techquity for Health Awards recognize leadership in equitable digital health innovation," said Janna Guinen, Executive Director of HLTH Foundation. "We're proud to honor each of our finalists and winners for showing us that a commitment to reducing health disparities at every stage of innovation unlocks the true potential of digital health to deliver better outcomes, stronger patient engagement, and healthcare cost containment."

Racial disparities in diabetes care persist, with African American and Asian patients experiencing lower adoption rates of continuous glucose monitoring (CGM), digital health tools, and newer therapeutics. Implicit and explicit provider biases, as well as systemic barriers, often limit access to intensive disease management, resulting in poorer glycemic control. Circadian Health has developed a virtual-first, technology-enabled care model to address these disparities and ensure that patients have equitable access to the latest advancements in diabetes treatment.

This initiative leverages seamless remote monitoring through cellular-enabled, easy-to-use glucose meters, and when appropriate, CGMs and other connected devices—eliminating the need for WiFi or complex digital platforms. Patients receive risk-stratified, personalized care plans managed by a dedicated nurse care manager who is also a Certified Diabetes Care and Education Specialist, with oversight from a nurse practitioner and an endocrinologist. Multilingual technology support and community health workers provide hands-on assistance to help patients navigate and engage with their care. Real-time physiological data review allows for timely interventions, medication adjustments, and targeted education, ensuring that patients receive the right care at the right time. Engagement is tailored to individual comfort levels, with options including text messaging, emails, phone calls, or video visits.

While this program launched in November 2024 and continues to actively engage patients, previous implementations of this model have already demonstrated its effectiveness in improving diabetes management for high-risk Medicaid populations. Key outcomes include:

• 65% of patients achieving an HbA1c below 9%
• 65% completion rate for diabetes kidney evaluations
• 85%+ medication adherence (statins, hypertension, anti-diabetes medications)
• Projected 10-point improvement in diabetes distress scores within six months
• 70% completion rate for post-discharge medication reconciliation and follow-up visits
• 15% reduction in diabetes-related emergency department visits, hospitalizations, and readmissions

"As we work to address disparities in diabetes care, we must focus on more than just expanding access—we need to ensure that access is truly equitable," said Chuck Hector, President and Co-Founder of Circadian Health. "Winning the HLTH Foundation's Techquity Award is an important recognition of our work, but more importantly, it's a validation of what's possible when we pair technology with compassionate, patient-centered care. We're breaking down barriers so that every patient—regardless of their background, income level, or digital literacy—can receive the high-quality, specialized treatment they deserve."

Circadian Health is committed to expanding this initiative to additional Medicaid markets and scaling its impact through partnerships with national health plans, employers, and risk-bearing entities. By integrating equitable access to diabetes technology with a compassionate, patient-centric approach, Circadian is not only closing care gaps but also redefining how chronic disease management can be delivered at scale.

About HLTH Foundation's Techquity for Health Awards

Techquity in healthcare (technology + health equity) is the intentional design, development, and distribution of technology to improve outcomes for underserved patients and address structural inequities in healthcare. It applies to digital health tools, programs, and data.

About Circadian Health

Circadian Health is revolutionizing chronic care management as the first and only virtual-first provider specializing in cardiometabolic care across all 50 states. Through AI-driven risk stratification, remote monitoring, and virtual access to top specialists, Circadian ensures timely, high-quality specialty care for heart failure, diabetes, and sleep disorders. With a hospital-at-home model, interoperable technology, and a commitment to health equity, Circadian is shaping the future of chronic disease management. For more information, visit Circadian Health at www.circadiancare.com and follow us on LinkedIn at Circadian Health.

SOURCE Circadian Health